CJC-1295 (No DAC)

CJC-1295 (No DAC) is a high-purity, research-grade peptide developed for laboratory and preclinical research as a strong analog of growth hormone-releasing hormone (GHRH). Without the inclusion of a Drug Affinity Complex (DAC), this peptide acts as a short-acting compound, allowing researchers to study growth hormone secretion, receptor interactions, and metabolic processes with accuracy and control.

Key Features:

• High-purity, research-grade peptide with reliable batch consistency

• Short-acting GHRH analog designed for in vitro and preclinical research

• Supports investigations into growth hormone signaling, metabolism, and endocrine function

• Includes clear handling, storage, and reconstitution guidelines to preserve peptide stability

Applications:

• Research on growth hormone release and pulsatile secretion patterns

• Analysis of endocrine receptor signaling and metabolic pathways

• Preclinical evaluation in regenerative and metabolic research studies

Safety and Handling:
For laboratory research use only. Not intended for human consumption or clinical use. Handle in accordance with standard laboratory safety practices and store under recommended conditions to maintain peptide integrity.